Posted in | News | Nanobusiness

Funds to Support Commercial Development of Nanotechnology-Based Energy Absorbing Material

San Diego Tech Coast Angels, a member of the largest angel network in the United States and the number one source of start-up funding in Southern California, announced today that the group's seed track has closed a Series A financing for AgileNano, a San Diego-based company developing technologies to minimize military injuries such as traumatic brain injury (TBI) resulting from explosions, and to increase comfort and protection of sporting equipment such as shoes and helmets.

The financing recently contributed by the San Diego Tech Coast Angels (TCA) seed track, along with contract funding provided by the Center for Commercialization of Advanced Technology (CCAT) San Bernardino and the Office of Technology Transfer & Commercialization at California State University San Bernardino, will allow AgileNano to complete product development of Agilezorb™, the company’s lead technology, and move it into commercial development.

Agilezorb is a liquid or gel that contains nanoporous, energy-absorbing particles. Sudden impact pressure rapidly forces the liquid into the normally empty nanopores, absorbing a tremendous amount of energy. The first use of this technology will likely be in military helmets, to help mitigate traumatic brain injury (TBI), a signature injury of the war in Iraq. A recent Rand Corporation report estimated that 320,000 of the 1.64 million troops deployed in Iraq and Afghanistan are affected by TBI. Additional, potential applications for Agilezorb include shoes, bicycle and other sports helmets, protective equipment, and electronics.

"The opportunity to fund a technology that has the potential to mitigate traumatic brain injuries among our troops was quite appealing to our membership,” said Tom Tierney, a member of San Diego TCA and lead investor in the AgileNano deal. "We were additionally impressed by the tremendous value proposition offered by AgileNano and Agilezorb, both in terms of the competitive advantages of the technology and its wide range of potential uses."

University of California San Diego Professor Yu Qiao, Agilenano's chief technology officer, invented Agilezorb while investigating energy absorbing nano-composites for helmets, bumpers, and body armor. His experiments demonstrated that energy absorption could be amplified hundreds or thousands of times by using a suspension of nanoporous particles in a liquid or a gel.

“Our research suggests that Agilezorb is the only known material that reacts fast enough to smoothen and lower the explosive shock front generated by Improvised Explosive Devices (IEDs), converting the shock into a slow rising, non-shock wave,” said Doug Giese, AgileNano CEO. “The prevailing opinion within the medical community is that the shock front is a primary cause of TBI. Conventional energy-absorbing materials, including padding materials currently used in military helmets, allow the shock wave to pass directly into the head and body. Recent tests at a U.S. Government facility showed that Agilezorb reduced blast wave pressure by more than 85 percent.

“The funding provided by TCA enables us to move this potentially life-saving technology through the final stages of research and into commercial development within the next year,” Giese said.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.